Predicting Acute Kidney Injury After Coronary Artery Bypass Graft

Sponsor
Samsung Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02081261
Collaborator
(none)
877
1
25
35.1

Study Details

Study Description

Brief Summary

Acute kidney injury after cardiac surgery is a major complication after cardiac surgery and has been reported to be associated with adverse outcome. There have been many studies reporting risk factor of acute kidney injury after cardiac surgery, but the influence of perioperative variables related to anesthesia and perioperative medication has not been evaluated fully. The investigators attempt to evaluate the influence of perioperative clinical variables including preoperative medication, preoperative albumin level, uric acid concentration, anesthesia technique, use of hydroxyethyl starch, blood glucose level, intraoperative medication, perioperative cardiac function (systolic and diastolic function) and hemodynamic variables during surgery on the incidence of acute kidney injury after coronary artery bypass graft.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Coronary artery bypass surgery

Detailed Description

Acute kidney injury (AKI) after cardiac surgery is a major complication after cardiac surgery and has been reported to be associated with adverse outcome. There have been many studies reporting risk factor of acute kidney injury after cardiac surgery, but the influence of perioperative variables related to anesthesia and perioperative medication has not been evaluated fully. The investigators attempt to evaluate the influence of preoperative medication, preoperative albumin level, uric acid concentration, NL ratio, anesthesia technique, use of hydroxyethyl starch, blood glucose level, intraoperative medication, perioperative cardiac function (systolic and diastolic) and hemodynamic variables during surgery on the incidence of acute kidney injury after coronary artery bypass graft. Preoperative and postoperative diastolic dysfunction may be associated with postoperative AKI. In addition, preoperative neutrophil-lymphocyte ratio (NLR) which has been reported to be a marked for systemic inflammation and was associated with prognosis in cardiac patients undergoing coronary artery bypass graft or percutaneous coronary intervention. This preoperative or immediate postoperative NLR might be able to predict AKI after coronary artery bypass surgery.

Study Design

Study Type:
Observational
Actual Enrollment :
877 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Predicting Acute Kidney Injury After Coronary Artery Bypass Graft : a Simplified Clinical Risk Scoring Model
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Feb 1, 2016
Actual Study Completion Date :
Feb 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Coronary artery bypass surgery

patients who underwent coronary artery bypass surgery between 2010 and 2012 in Samsung Medical Center

Procedure: Coronary artery bypass surgery
coronary artery bypass surgery

Outcome Measures

Primary Outcome Measures

  1. Acute kidney injury diagnosis defined by KDIGO criteria [during 7 days after surgery]

    Acute kidney injury diagnosis defined by KDIGO criteria (Stage 1, 2, 3) during seven days after surgery

Secondary Outcome Measures

  1. Acute kidney injury as defined by AKIN (acute kidney injury network) criteria [within 48 hours after surgery]

    Acute kidney injury as defined by AKIN (acute kidney injury network) criteria

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients who underwent coronary artery bypass surgery during between 2010 and 2012 in Samsung Medical Center
Exclusion Criteria:
  • lack of postoperative creatinine or urine output data

  • patients who expired within 24hours after surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Samsung Medical Center Seoul Korea, Republic of 135-710

Sponsors and Collaborators

  • Samsung Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
WonHo Kim, Assistant Professor, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT02081261
Other Study ID Numbers:
  • 2013-12-116
First Posted:
Mar 7, 2014
Last Update Posted:
Jun 16, 2016
Last Verified:
Jun 1, 2016
Keywords provided by WonHo Kim, Assistant Professor, Samsung Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 16, 2016